05/15/2026 | Press release | Distributed by Public on 05/15/2026 09:03
|
Maryland
|
|
85-3467693
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☒
|
Smaller reporting company
|
☒
|
|
Emerging growth company
|
☒ |
|
|
• |
Registration Statement on Form S-8 (Registration No. 333-253938), which was filed with the Commission on March 5, 2021, registering Shares issuable under the Helix TCS, Inc. 2017 Omnibus Stock Incentive Plan, the Bio-Tech Medical Software, Inc. 2014 Stock Incentive Plan and the Forian Inc. 2020 Equity Incentive Plan (the "2020 Plan").
|
|
|
• |
Registration Statement on Form S-8 (Registration No. 333-268470), which was filed with the Commission on November 18, 2022, registering Shares issuable under the 2020 Plan.
|
|
|
• |
Registration Statement on Form S-8 (Registration No. 333-289649), which was filed with the Commission on August 15, 2025, registering Shares issuable under the 2020 Plan.
|
|
FORIAN INC.
|
||
|
By:
|
/s/ Max Wygod
|
|
|
Name: Max Wygod
|
||
|
Title: President and Chief Executive Officer
|
||